Clinical Trial Market, Share, Growth, Trends and Forecast to 2032: Global Market Insights

1
Clinical Trial Market Growth Prospects, Key
Vendors, Future Scenario Forecast to 2032
2

• Industry Insights

• Clinical Trial Imaging Market size is projected
  to expand at 7.9 CAGR from 2023-2032 driven by
  the expanding biopharmaceutical sector across the
  globe.
• Biopharmaceutical companies, engaged in the
  development of novel therapies, increasingly rely
  on advanced imaging services to assess drug
  efficacy and safety.
• With the growing focus of the biopharma companies
  on precision medicine and targeted therapies, the
  demand for robust and specialized imaging
  solutions in clinical trials is rising.
• Furthermore, key players are investing in
  cutting-edge solutions, including AI applications
  for image interpretation for catering to the
  increasing demand for precise and real-time data,
  whilst attracting sponsors and researchers
  seeking state-of-the-art imaging services,
  further accelerating the industry expansion.

3

• For instance, in March 2023, Clario launched a
  cloud-based Image Viewer application for sponsors
  and contract research organizations (CROs) to
  examine clinical trial images.
• As per service, the clinical trial design
  consultation services market gained significant
  traction in 2022 and is anticipated to depict
  8.7 growth rate during 2023-2032.
• Clinical trial design and consultation services
  are witnessing high demand for planning imaging
  protocols for ensuring regulatory compliance and
  optimizing trial efficiency.
• With pharmaceutical and biotechnology companies
  increasingly recognizing the importance of
  imaging endpoints in clinical trials, the demand
  for specialized design and consultation services
  is also rising.
• In terms of end-user, the clinical trial imaging
  market from the medical devices manufacturers
  segment is estimated to expand at 7.3 CAGR from
  2023 to 2032. Medical device manufacturers are
  increasingly incorporating imaging technologies
  in clinical trials to assess product efficacy and
  safety.

4

• Regional Analysis

• Regionally, the Asia Pacific clinical trial
  imaging industry is set to exhibit 8.8 CAGR
  between 2023 and 2032 attributed to the
  increasing clinical research activities and the
  growing emphasis on healthcare innovation. The
  presence of diverse patient population and the
  higher availability of cost-effective clinical
  trial solutions in the region are attracting
  investments from multinational pharmaceutical
  companies.

• Competitive Analysis

• Image Core Lab
• WCG Clinical
• Ixico PLC
• Medspace Holdings Inc.
• Resonance Health Limited Median Technologies
• WorldCare Clinical
• Navitas Clinical Research, Inc

5
Clinical Trial Imaging Market _at_
https//www.gminsights.com/industry-analysis/clini
cal-trial-imaging-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/7
394
Request for customization _at_ https//www.gminsights
.com/roc/7394
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com